High-Dose Therapy and Autologous Stem Cell Transplantation for Chemoresistant Hodgkin Lymphoma: The Seattle Experience

BACKGROUND: High-dose therapy (HDT) with autologous stem cell transplantation (ASCT) is the standard treatment for patients with chemosensitive relapsed/refractory Hodgkin lymphoma (HL), but this therapy is commonly denied to patients with resistant disease. We explored the utility of HDT and ASCT f...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gopal, Ajay K, Metcalfe, Tracee L, Gooley, Ted A, Pagel, John M, Petersdorf, Stephen H, Bensinger, William I, Holmberg, Leona, Maloney, David G, Press, Oliver W
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2700660/
https://ncbi.nlm.nih.gov/pubmed/18623377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23715
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky